Literature DB >> 630297

Unusual fetal malformations after antiemetics in early pregnancy.

R Harris.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 630297      PMCID： PMC1603039          DOI： 10.1136/bmj.1.6114.691

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  1 in total

1.  Antenatal exposure to doxylamine succinate and dicyclomine hydrochloride (Benedectin) in relation to congenital malformations, perinatal mortality rate, birth weight, and intelligence quotient score.

Authors:  S Shapiro; O P Heinonen; V Siskind; D W Kaufman; R R Monson; D Slone
Journal:  Am J Obstet Gynecol       Date:  1977-07-01       Impact factor: 8.661
  1 in total
  8 in total

1.  Antinauseants in pregnancy: teratogens or not?

Authors:  A Biringer
Journal:  Can Fam Physician       Date:  1984-10       Impact factor: 3.275

2.  Is vomiting during pregnancy teratogenic?

Authors:  M A Klebanoff; J L Mills
Journal:  Br Med J (Clin Res Ed)       Date:  1986-03-15

3.  Bendectin: the wrong way to regulate drug availability.

Authors:  J S Leeder; S P Spielberg; S M MacLeod
Journal:  Can Med Assoc J       Date:  1983-11-15       Impact factor: 8.262

4.  Crying wolf on drug safety.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1982-01-23

5.  Debendox and congenital malformations in Northern Ireland.

Authors:  D W Harron; K Griffiths; R G Shanks
Journal:  Br Med J       Date:  1980-11-22

6.  Maternal drug histories and central nervous system anomalies.

Authors:  K A Winship; D A Cahal; J C Weber; J P Griffin
Journal:  Arch Dis Child       Date:  1984-11       Impact factor: 3.791

7.  Debendox in early pregnancy and fetal malformation.

Authors:  D M Fleming; J D Knox; D L Crombie
Journal:  Br Med J (Clin Res Ed)       Date:  1981-07-11

8.  Inter-Regional Epidemiological Study of Childhood Cancer (IRESCC): childhood cancer and the consumption of debendox and related drugs in pregnancy.

Authors:  P A McKinney; R A Cartwright; C A Stiller; P A Hopton; J R Mann; J M Birch; A L Hartley; J A Waterhouse; H E Johnston
Journal:  Br J Cancer       Date:  1985-12       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.